IT1176613B - Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione - Google Patents

Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione

Info

Publication number
IT1176613B
IT1176613B IT22334/84A IT2233484A IT1176613B IT 1176613 B IT1176613 B IT 1176613B IT 22334/84 A IT22334/84 A IT 22334/84A IT 2233484 A IT2233484 A IT 2233484A IT 1176613 B IT1176613 B IT 1176613B
Authority
IT
Italy
Prior art keywords
piperazinic
derivatives
preparation
pharmacologically active
pharmacologically
Prior art date
Application number
IT22334/84A
Other languages
English (en)
Other versions
IT8422334A0 (it
Inventor
Francesco Botre
Roberto Signorini
Original Assignee
Ravizza Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ravizza Spa filed Critical Ravizza Spa
Priority to IT22334/84A priority Critical patent/IT1176613B/it
Publication of IT8422334A0 publication Critical patent/IT8422334A0/it
Priority to EP85108942A priority patent/EP0171636A1/en
Priority to US06/756,257 priority patent/US4940793A/en
Priority to JP60177809A priority patent/JPS6156167A/ja
Application granted granted Critical
Publication of IT1176613B publication Critical patent/IT1176613B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IT22334/84A 1984-08-14 1984-08-14 Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione IT1176613B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT22334/84A IT1176613B (it) 1984-08-14 1984-08-14 Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
EP85108942A EP0171636A1 (en) 1984-08-14 1985-07-17 Pharmacologically active piperazino derivatives and the process for their preparation
US06/756,257 US4940793A (en) 1984-08-14 1985-07-18 Pharmacologically active piperazino derivatives
JP60177809A JPS6156167A (ja) 1984-08-14 1985-08-14 薬学的に活性なピペラジノ誘導体及びその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22334/84A IT1176613B (it) 1984-08-14 1984-08-14 Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione

Publications (2)

Publication Number Publication Date
IT8422334A0 IT8422334A0 (it) 1984-08-14
IT1176613B true IT1176613B (it) 1987-08-18

Family

ID=11194823

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22334/84A IT1176613B (it) 1984-08-14 1984-08-14 Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione

Country Status (4)

Country Link
US (1) US4940793A (it)
EP (1) EP0171636A1 (it)
JP (1) JPS6156167A (it)
IT (1) IT1176613B (it)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY102447A (en) * 1986-06-16 1992-06-30 Ciba Geigy Ag Disubtituted piperazines
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
EP0723542A4 (en) * 1993-06-04 1996-10-23 Henkel Corp POLYMERIZABLE CONNECTIONS
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
US5856326A (en) * 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US5885995A (en) * 1996-04-03 1999-03-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5859015A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase
US5972942A (en) * 1997-03-27 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO2000051614A1 (en) * 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US7046924B2 (en) 2002-11-25 2006-05-16 Eastman Kodak Company Method and computer program product for determining an area of importance in an image using eye monitoring information
US7327890B2 (en) 2002-12-20 2008-02-05 Eastman Kodak Company Imaging method and system for determining an area of importance in an archival image
DK1656361T3 (da) 2003-08-11 2008-05-05 Hoffmann La Roche Piperazin med OR-substitueret phenylgruppe og anvendelse deraf som GLYT1-inhibitorer
CN100522171C (zh) * 2003-09-09 2009-08-05 弗·哈夫曼-拉罗切有限公司 作为甘氨酸摄取抑制剂、用于治疗精神病的1-苯甲酰基哌嗪衍生物
BRPI0414209B8 (pt) * 2003-09-09 2021-05-25 Hoffmann La Roche derivados de 1-(2-amino-benzol)-piperazina, seus processos de preparação e seu uso, e medicamento
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
KR20070014184A (ko) * 2004-04-22 2007-01-31 베링거 인겔하임 인터내셔날 게엠베하 성기능 장애 치료용 신규 약제학적 조성물 ⅱ
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
EP1828154B1 (en) 2004-12-09 2009-04-29 F. Hoffmann-Roche AG Phenyl-piperazin methanone derivatives
RU2007121768A (ru) 2004-12-15 2009-01-27 Ф. Хоффманн-Ля Рош Аг (Ch) Би- и трициклически замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения болезни альцгеймера
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
JP5006799B2 (ja) * 2005-01-07 2012-08-22 エフ.ホフマン−ラ ロシュ アーゲー 神経疾患及び精神神経疾患の処置用のグリシントランスポーター1(glyt−1)阻害剤としての[4−(ヘテロアリール)ピペラジン−1−イル]−(2,5−置換フェニル)−メタノン誘導体
AU2006207650B2 (en) 2005-01-18 2011-01-27 F. Hoffmann-La Roche Ag 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders
WO2006079467A1 (en) 2005-01-26 2006-08-03 F. Hofmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
DE602006010665D1 (en) 2005-02-07 2010-01-07 Hoffmann La Roche Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
CA2599721A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
JP2008540356A (ja) * 2005-05-06 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬物乱用の治療方法
WO2006125042A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
JP2008540672A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 病状に起因する性的機能不全の治療方法
WO2007014929A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Use of flibanserin in the treatment of obesity
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
WO2007103456A2 (en) * 2006-03-06 2007-09-13 Trimeris, Inc. Piperazine and piperidine biaryl derivatives
KR20090005371A (ko) * 2006-05-09 2009-01-13 베링거 인겔하임 인터내셔날 게엠베하 폐경후 성욕 장애의 치료를 위한 플리반세린의 용도
WO2008000760A1 (en) * 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
JP2009543839A (ja) * 2006-07-14 2009-12-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 女性の性的障害を治療するためのフリバンセリンの使用
EP2054041A2 (en) * 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations of flibanserin and method for manufacturing the same
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CN101505736A (zh) * 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放***及其制造方法
PE20091188A1 (es) * 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
MX2010010525A (es) * 2008-03-24 2010-10-25 Novartis Ag Inhibidores de metaloproteasa de matriz basados en aril-sulfonamida.
HUE046820T2 (hu) 2014-03-26 2020-03-30 Hoffmann La Roche Biciklusos vegyületek autotaxin (ATX) és lizofoszfatidsav (LPA) termelésgátlókként
CR20180058A (es) 2015-09-04 2018-02-26 Hoffmann La Roche Nuevos derivados de fenoximetilo
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502319A (it) * 1950-04-04
FR1267777A (fr) * 1959-03-03 1961-07-28 Geigy Ag J R Nouveaux sulfamyl-benzamides et leur préparation
IL33030A0 (en) * 1968-10-03 1969-11-30 Du Pont 1-carbamoylpyrazole-4-sulfonamides and pharmaceutical compositions containing them
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
US3865828A (en) * 1972-03-22 1975-02-11 Egyt Gyogyszervegyeszeti Gyar Pyridine derivatives having antidepressant activity
DE2414498B2 (de) * 1974-03-26 1980-10-09 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von N- [(l-Äthyl-2pyrrolidinyl)-methyl] -2- alkoxy-5sulfamoylbenzamidderivaten
DE2442851A1 (de) * 1974-09-06 1976-03-18 Hoechst Ag Basisch substituierte 3-sulfamoylbenzoesaeurederivate und verfahren zu ihrer herstellung
DE2611705A1 (de) * 1976-03-18 1977-09-22 Josef Dipl Chem Dr Rer N Klosa N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel
US4097263A (en) * 1976-11-22 1978-06-27 Gulf Oil Corporation 5-Acylamino-1,3,4-thiadiazole-2-sulfonamides and use as herbicides
FR2396757A2 (fr) * 1977-07-08 1979-02-02 Ile De France Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
ES8308553A1 (es) * 1982-06-17 1983-09-01 Ferrer Int "procedimiento de obtencion de nuevos derivados de piperazina".

Also Published As

Publication number Publication date
EP0171636A1 (en) 1986-02-19
JPS6156167A (ja) 1986-03-20
US4940793A (en) 1990-07-10
IT8422334A0 (it) 1984-08-14

Similar Documents

Publication Publication Date Title
IT1176613B (it) Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
IT8567743A0 (it) Derivati di benzimidazolo procedimento per la loro preparazione e agenti antiulcera che li contengono
IT1196488B (it) Poli-4-aminopirrol-2-carbossamido derivati e procedimento per la loro preparazione
IT1199148B (it) Derivati spirosuccinimidici ed il processo per la loro preparazione
IT1208807B (it) Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione
IT1157298B (it) N-imidazolil derivati di 1,2,3,4-tetraidronaftalene, indano e 2-sostituito-1-cromano e processo per la loro preparazione
IT1185828B (it) Derivati del calcone e procedimento per la loro preparazione
IT8747874A0 (it) La loro preparazione derivati tiodiossolanici ad attivita' moculitica e procedimento per
IT8547862A0 (it) Derivati piridinici e procedimenti per la loro preparazione
IT8819958A0 (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
IT1214726B (it) Derivati di glucosilmoranolina eprocedimento per la loro preparazione
IT1231933B (it) Derivati 4 amminofenilici cicloalchil sostituiti e processo per la loro preparazione.
IT1142620B (it) Derivati piperazinici 1,4-bisostituiti e processo per la loro preparazione
IT1217342B (it) Derivati piperazinici e procedimento per la loro preparazione
IT1199830B (it) 10 b-alchinil-4,9(11)-estradiene derivati e procedimento per la loro preparazione
IT1231734B (it) Derivati imidazolici 1,5 disostituiti e processo per la loro preparazione
IT1200399B (it) 1-nor-2-idrossi-metil-derivati di carboprostacicline e procedimento per la loro preparazione
IT1183478B (it) 13,14,19,20-tetradeidro derivati di carboprostaciline e procedimento per la loro preparazione
IT1183477B (it) 13,14,19,19,20,20-esadeidro derivati di carbostacicline e procedimento per la loro preparazione
IT1183479B (it) Furil ed imidazolil derivati di carboprostacicline e procedimento per la loro preparazione
IT8921601A0 (it) Derivati 4 amminofenilici cicloalchil sostituiti e processo per la loro preparazione.
IT1209900B (it) Derivati benzanilidici dotati di attivita' farmacologica e procedimento per la loro produzione
IT1213435B (it) 10beta-alo-alchinil-estrene derivati e procedimento per la loro preparazione.
IT1171605B (it) Derivati di acido 4-fenil-4-ossobuten-2-oico farmacologicamente attivi e procedimento per la loro preparazione
IT1173448B (it) Composti poliossidrilati e loro derivati e procedimento per ottenerli